| Literature DB >> 27806320 |
Lianjun Pan1, Daoxian Qiu2, Jingyun Li3, Jun Li3, Pu Xu4, Dan Zhao1, Jiehua Ma1.
Abstract
BACKGROUND: It has been proved that human voltage-dependent anion channel 2 (VDAC2) plays a significant role in sperm function and male fertility. This study was primarily aimed at exploring whether VDAC2 is a risk factor for idiopathic male infertility.Entities:
Keywords: VDAC2; genetic diversity; idiopathic male infertility; semen parameters
Mesh:
Substances:
Year: 2016 PMID: 27806320 PMCID: PMC5347716 DOI: 10.18632/oncotarget.12993
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Association between the selected individual characteristics and sperm parameters in 523 males with definite idiopathic infertility
| N (%) | Semen volume (mL) | Concentration (× 106/mL) | Sperm number per ejecalate (×106/ejaculum) | Motility (%) | |
|---|---|---|---|---|---|
| ≤ 29 | 183 (34.99) | 3.27 ± 1.35 | |||
| 29–33 | 183 (34.99) | 3.39 ± 1.41 | |||
| > 33 | 157 (30.02) | 3.39 ± 1.27 | |||
| Yes (ever) | 260 (49.71) | 3.31 ± 1.22 | 3.71 ± 1.16 | 4.87 ± 1.21 | 48.12 ± 24.45 |
| No (never) | 263 (50.29) | 3.38 ± 1.47 | 3.79 ± 1.16 | 4.94 ± 1.26 | 47.07 ± 25.78 |
| Yes (ever) | 207 (39.58) | 3.30 ± 1.36 | 3.66 ± 1.25 | 4.81 ± 1.33 | 45.32 ± 26.20 |
| No (never) | 316 (60.42) | 3.37 ± 1.34 | 3.80 ± 1.09 | 4.97 ± 1.18 | 49.08 ± 24.30 |
| < 20 | 49 (9.37) | 3.25 ± 1.22 | 44.70 ± 27.61 | ||
| 20–25 | 293 (56.02) | 3.33 ± 1.36 | 46.98 ± 24.53 | ||
| ≥ 25 | 181 (34.61) | 3.40 ± 1.37 | 49.37 ± 25.35 | ||
| < 4 | 190 (36.33) | 3.63 ± 1.13 | 49.50 ± 25.74 | ||
| 4–7 | 203 (38.81) | 3.76 ± 1.10 | 48.26 ± 24.36 | ||
| ≥ 7 | 130 (24.86) | 3.91 ± 1.28 | 43.77 ± 25.12 | ||
Values are mean ± SD unless otherwise stated.
BMI = body mass index; Abs = the duration of sexual abstinence.
Values were re-transformed following Logarithmic transformation.
P < 0.05 for comparison between groups using analysis of variance (ANOVA).
Sperm parameters according to the genetic variants of VADC2 gene in 523 males with definite idiopathic infertility
| Variant | Genotype | N (%) | Semen volume (mL) | Concentration | Sperm number per ejecalate | Motility (%) |
|---|---|---|---|---|---|---|
| rs2804535 | TT | 443 (84.70) | 3.38 ± 1.34 | 3.76 ± 1.14 | 4.94 ± 1.21 | 48.17 ± 25.38 |
| TC | 80 (15.30) | 3.16 ± 1.37 | 3.69 ± 1.24 | 4.73 ± 1.35 | 44.38 ± 23.48 | |
| CC | 0 (0.00) | - | - | - | - | |
| TC + CC | 80 (15.30) | 3.16 ± 1.37 | 3.69 ± 1.24 | 4.73 ± 1.35 | 44.38 ± 23.48 | |
| rs7896741 | GG | 300 (57.36) | 3.36 ± 1.30 | 3.70 ± 1.23 | 4.86 ± 1.28 | 48.12 ± 24.22 |
| GC | 193 (36.90) | 3.36 ± 1.46 | 3.81 ± 0.99 | 4.98 ± 1.14 | 46.76 ± 25.90 | |
| CC | 30 (5.74) | 3.06 ± 1.10 | 3.81 ± 1.37 | 4.88 ± 1.46 | 47.69 ± 29.20 | |
| GC + CC | 223 (42.64) | 3.32 ± 1.41 | 3.81 ± 1.04 | 4.97 ± 1.18 | 46.89 ± 26.30 | |
| rs11001334 | CC | 453 (86.62) | 3.34 ± 1.36 | 3.76 ± 1.15 | 4.91 ± 1.23 | 46.70 ± 25.48 |
| CT | 69 (13.19) | 3.34 ± 1.29 | 3.72 ± 1.21 | 4.88 ± 1.25 | ||
| TT | 1(0.19) | 4.20 ± 0.00 | 3.05 ± 0.00 | 16.38 ± 0.00 | ||
| CT + TT | 70 (13.38) | 3.36 ± 1.29 | 3.69 ± 1.23 | 4.85 ± 1.26 | ||
| rs1259503 | GG | 194 (37.09) | 3.49 ± 1.29 | 3.74 ± 1.13 | 4.94 ± 1.18 | 49.88 ± 24.82 |
| GC | 250 (47.80) | 3.79 ± 1.16 | 4.94 ± 1.24 | 45.73 ± 24.79 | ||
| CC | 79 (15.11) | 3.18 ± 1.28 | 3.62 ± 1.23 | 4.69 ± 1.35 | 47.86 ± 26.64 | |
| GC + CC | 329 (62.91) | 3.75 ± 1.18 | 4.88 ± 1.27 | 46.24 ± 25.22 |
All P-values were adjusted for age, smoking, drinking, body mass index (BMI) and the duration of sexual abstinence (Abs).
Values are mean ± SD unless otherwise stated.
Values are re-transformed following Logarithmic transformation.
P < 0.05 for comparison between rs11001334 CT and CC genotype (P = 0.026).
P < 0.05 for comparison between rs11001334 TT and CC genotype (P = 0.045).
P < 0.05 for comparison between rs11001334 CT+TT and CC genotype (P = 0.037).
P = 0.060 for comparison between rs1259503 GC and GG genotype.
P < 0.05 for comparison between rs1259503 GC+CC and GG genotype (P = 0.039).
Genotype frequencies of VADC2 genetic variants among the cases and controls and their association with male infertility
| SNPs | Genotype | Control | Case group 1 | Case group 2 | ||||
|---|---|---|---|---|---|---|---|---|
| rs2804535 | ||||||||
| TT | 205 (85.06) | 127 (89.44) | 1.00 | 316 (82.94) | 1.00 | |||
| TC | 34 (14.11) | 15 (10.56) | 0.608 | 0.86 (0.50–1.51) | 65 (17.06) | 0.645 | 1.24 (0.79–1.95) | |
| CC | 2 (0.83) | 0 | 0 | |||||
| TC + CC | 36 (14.94) | 15 (10.56) | 0.226 | 0.67 (0.35–1.28) | 65 (17.06) | 0.488 | 1.17 (0.75–1.83) | |
| rs7896741 | ||||||||
| GG | 143 (59.34) | 81 (57.04) | 1.00 | 219 (57.48) | 1.00 | |||
| GC | 85 (35.27) | 51 (35.92) | 0.781 | 1.06 (0.68–1.65) | 142 (37.27) | 0.714 | 1.09 (0.78–1.54) | |
| CC | 13 (5.39) | 10 (7.04) | 1.36 (0.57–3.24) | 20 (5.25) | 1.01 (0.48–2.08) | |||
| GC + CC | 98 (40.66) | 61 (42.96) | 0.660 | 1.10 (0.72–1.67) | 162 (42.52) | 0.648 | 1.08 (0.78–1.50) | |
| rs11001334 | ||||||||
| CC | 197 (81.74) | 119 (83.80) | 1.00 | 334 (87.66) | 1.00 | |||
| CT | 44 (18.26) | 23 (16.20) | 0.608 | 0.87 (0.50–1.51)) | 46 (12.07) | 0.069 | 0.83 (0.53–1.12) | |
| TT | 0 | 0 | 1 (0.26) | |||||
| CT + TT | 44 (18.26) | 23 (16.20) | 0.608 | 0.87 (0.50–1.51) | 47 (12.33) | 0.062 | 0.80 (0.64–1.11) | |
| rs1259503 | ||||||||
| GG | 95 (39.42) | 65 (45.77) | 1.00 | 129 (33.86) | 1.00 | |||
| GC | 113 (46.89) | 54 (38.03) | 0.107 | 0.70 (0.44–1.10) | 196 (51.44) | 0.446 | 1.28 (0.90–1.82) | |
| CC | 33 (13.69) | 23 (16.20) | 1.02 (0.55–1.89) | 56 (14.70) | 1.25 (0.75–2.07) | |||
| GC + CC | 146 (60.58) | 77 (54.23) | 0.224 | 0.77 (0.51–1.17) | 252 (66.14) | 0.160 | 1.27 (0.91–1.78) | |
Group 1: a + b > 50%, Semen volume (mL) > 2 ml, Concentration > 20 × 106ml.
Group 2: Subjects consisted of idiopathic infertile men with at least one of the abnormal semen parameters (semen volume, sperm concentration, sperm number per ejaculum and sperm motility).
P values were obtained using two-sided χ2 test for genotype distributions between cases and controls.
ORs were obtained from multivariate logistic regression analysis.
Genotype frequencies of VADC2 genetic variants among the cases and controls and their association with male infertility
| SNPs | Genotype | control | Subgroup 1 | Subgroup 2 | Subgroup 3 | Subgroup 4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rs2804535 | ||||||||||||||
| TT | 205 (85.06) | 294 (83.29) | 1.00 | 19 (67.86) | 1.00 | 115 (83.94) | 1.00 | 93 (84.55) | 1.00 | |||||
| TC | 34 (14.11) | 59 (16.71) | NS | 1.21 (0.77–1.91) | 9 (32.14) | 22 (16.06) | NS | 1.15 (0.64–2.07) | 17 (15.45) | NS | 1.10 (0.59–2.07) | |||
| CC | 2 (0.83) | 0 | 0 | 0 | 0 | |||||||||
| TC+CC | 36 (14.94) | 59 (16.71) | NS | 1.14 (0.73–1.79) | 9 (32.14) | 22 (16.06) | NS | 1.09 (0.61–1.94) | 17 (15.45) | NS | 1.04 (0.56–1.95) | |||
| rs7896741 | ||||||||||||||
| GG | 143 (59.34) | 205 (58.07) | 1.00 | 17 (60.71) | 1.00 | 80 (58.39) | 1.00 | 64 (58.18) | 1.00 | |||||
| GC | 85 (35.27) | 129 (36.54) | NS | 1.06 (0.74–1.50) | 10 (35.71) | NS | 0.99 | 47 (34.31) | NS | 0.99 (0.63–1.55) | 37 (33.64) | NS | 0.97 (0.60–1.58) | |
| CC | 13 (5.39) | 19 (5.38) | 1.02 (0.49–2.13) | 1 (3.75) | 0.64 | 10 (7.30) | 1.38 | 9 (8.18) | 1.55 (0.63–3.80) | |||||
| GC + CC | 98 (40.66) | 148 (41.93) | NS | 1.05 (0.76–1.47) | 11 (39.29) | NS | 0.94 | 57 (41.61) | NS | 1.04 (0.68–1.59) | 46 (41.82) | 1.05 (0.66–1.66) | ||
| rs11001334 | ||||||||||||||
| CC | 197 (81.74) | 311 (88.10) | 1.00 | 25 (89.29) | 1.00 | 119 (86.86) | 1.00 | 96 (87.27) | 1.00 | |||||
| CT | 44 (18.26) | 41 (11.61) | 3 (10.71) | NS | 0.54 (0.16–1.86) | 17 (12.41) | NS | 0.64 (0.35–1.17) | 13 (11.82) | NS | 0.61 (0.31–1.18) | |||
| TT | 0 | 1 (0.28) | 0 | 1 (0.73) | 1 (0.91) | |||||||||
| CT + TT | 44 (18.26) | 45 (11.89) | 3 (10.71) | NS | 0.54 | 18 (13.14) | NS | 0.68 (0.37–1.23) | 14 (12.73) | NS | 0.65 (0.34–1.25) | |||
| rs1259503 | ||||||||||||||
| GG | 95 (39.42) | 124 (35.13) | 1.00 | 7 (25.00) | 1.00 | 51 (37.23) | 1.00 | 41 (37.27) | 1.00 | |||||
| GC | 113 (46.89) | 180 (50.99) | NS | 1.22 (0.86–1.91) | 15 (53.57) | NS | 1.80 (0.71–4.60) | 61 (44.53) | NS | 1.01 (0.63–1.60) | 50 (45.45) | NS | 1.03 (0.63–1.68) | |
| CC | 33 (13.69) | 49 (13.88) | 1.14 (0.68–1.91) | 6 (21.43) | 2.47 (0.77–7.87) | 25 (18.25) | 1.41 (0.76–2.63) | 19 (17.27) | 1.33 (0.68–2.62) | |||||
| GC + CC | 146 (60.58) | 229 (64.87) | NS | 1.20 (0.96–1.69) | 21 (75.00) | NS | 1.95 | 86 (62.77) | NS | 1.10 (0.71–1.69) | 69 (62.73) | NS | 1.10 (0.69–1.74) | |
Subgroup1: a + b < 50%; Subgroup2: semen volume < 2 ml; Subgroup3: sperm concentration < 20 × 106 ml; Subgroup4: sperm number per ejaculum < 40 × 106
P values were obtained using two-sided χ2 test for genotype distributions between cases and controls.
ORs were obtained from multivariate logistic regression analysis.
NS, not statistically significant.
Figure 1The overlook of the chosen tagging single nucleotide polymorphisms (tagSNPs) and the individual characteristics
(A) Site of the four SNPs in the VDAC2 gene and 1500 base pairs (bp) upstream and 1500 bp downstream region. The selected tagSNPs are indicated by red frame. (B) TagSNPs are evaluated in a indirect way by the listed r2 values correspond. MAF = minor allele frequency.